NRIXNurix Therapeutics, Inc.
$22.36+165% 1Y
$22.36
$8.2452 weeks$27.79
Is the price fair?
What NRIX's price assumes
Nurix Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 27.7× revenue.
27.7
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 4.31
Price / book · today's price, fiscal year to Nov 30, 2025
- EV / sales
- 24.7
EV / sales
Details›
- Price / booktoday's price, fiscal year to Nov 30, 2025
- 4.31
- EV / EBIToperating margin −982%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, fiscal year to Nov 30, 2025
- 24.7
- Market capitalisation
- $2.32B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks